Suchergebnisse - "Van Hoorick, Benjamin"

PubPharm (5)

1

LTA4H inhibitor LYS006 : Clinical PK/PD and safety in a randomized phase I clinical trial

enthalten in: Clinical and translational science | 2024

von Loesche, C. | Picard, D. | Van Hoorick, B. | +12

2

LTA4H inhibitor LYS006 : Clinical PK/PD and safety in a randomized phase I clinical trial

enthalten in: Clinical and Translational Science | 2024

von Loesche, C. | Picard, D. | Van Hoorick, B. | +12

3

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+) : interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

enthalten in: Frontiers in neurology | 2023

von Howard, J. | Bril, V. | Vu, T. | +15

4

Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI) : Phase 1, Randomized, Open-Label, Parallel-Group Trials

enthalten in: Rheumatology and therapy | 2018

von Ramael, S. | Van Hoorick, B. | Tiessen, R. | +7

5

Similar Pharmacokinetics of the Adalimumab ($ Humira^{®} $) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe ($ VOLTAIRE^{®} $-AI and $ VOLTAIRE^{®} $-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials

enthalten in: Rheumatology and therapy | 2018

von Ramael, S. | Van Hoorick, B. | Tiessen, R. | +7

1
[1]